Nanotech nurtures unique treatment for inoperable cancers
pharmaphorum - 18-Dec-2020Innovate UK is funding specialists of nanotechnology & bioimaging to cure cancer
Join the club for FREE to access the whole archive and other member benefits.
Chief Technical Officer at Xerion Healthcare
Following a BSc and PhD in Physics at the University of Bristol, Dr Wakefield spent five years at the University of Oxford researching novel applications of nanoparticles and quantum semiconductors. Dr Wakefield has over 15 years of experience of developing nanoparticle technology in University of Oxford spin out companies, Oxonica and Oxford Advanced Surfaces. Dr Wakefield co-founded Oxonica in 1999, managing the technical team through development of Optisol sunscreen additives and Envirox diesel catalysts and through to Oxonica’s successful AIM listing in summer 2005.
Visit website: https://xerionhealthcare.co.uk/about/team/#dr-gareth-wakefield
See also: Xerion Healthcare - Company that works with novel nanoparticle systems
Details last updated 19-Dec-2020
Innovate UK is funding specialists of nanotechnology & bioimaging to cure cancer